Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...
The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...
GLP-1 medications like Ozempic and Mounjaro can influence the volume of all-cause hospital admissions and bariatric surgeries, two studies suggest. Researchers at Boston-based Harvard Medical School ...
Denmark-based Novo Nordisk teased some new details about a potential Ozempic successor during a call with investors on Tuesday. Sales of the company’s current blockbuster weight loss drug, Wegovy, ...
Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...
It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits. Ozempic is part of a drug class known as GLP-1 medications, which mimic gut hormones that help ...